Advertisement

NLS Pilloxa

Collaboration - June 16, 2021

Pilloxa enters new collaboration

Pilloxa has announced that it is to collaborate with the Nordic office of Chiesi Global Rare Diseases on using the company’s platform to support the treatment journey for patients with nephropathic cystinosis across Scandinavia. “We are honored to work with the Nordic office of Chiesi Global Rare Diseases to support patients, an incredible partner within […]

Clinical Trials - February 17, 2021

Pilloxa and University of Oslo start collaborative trial

Pilloxa has announced the start of a single-armed and multicenter observational clinical trial in which their digital patient-centric adherence solution will be tested in patients with cardiovascular disease, namely newly diagnosed patients with atrial fibrillation. The study, ASTORIA, to be conducted as a multicenter trial with the University of Oslo as lead, is funded by […]

Financing - August 20, 2020

Pilloxa receives 580k EUR from EU

The company has received 580k EUR in funding from the EU’s EUROSTARS program. Pilloxa is developing digital patient-centric solutions and will, together with the University of Oslo, now validate an innovation that supports the patient to take their medication as prescribed and further develop the solution to increase the quality and effectiveness of drug treatment […]

MedTech Award - August 16, 2019

Swedish companies nominated for “Medtech Oscars”

Elypta, Pilloxa and Sigrid Therapeutics have been announced as finalists in this year’s Medtech Insight Awards, an award that celebrates and recognizes excellence among the companies, teams, and individuals driving positive change across the global medtech industry. Ten distinct categories cover notable achievements across the device and diagnostics industries, from technological innovations and partnerships, to […]

Collaboration - March 20, 2019

Pilloxa in strategic partnership with Bayer

Swedish Pilloxa is initiating a collaboration with the Scandinavian branch of Bayer and get the opportunity to introduce more people to their smart pillbox through Bayer’s network, both in Scandinavia and globally. “We see great potential in this innovation. For someone not too familiar in the subject it might seem like a trivial task to take […]

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.